Back
Apyx Medical 10K Form
Buy
56
APYX
Apyx Medical
Last Price:
1.42
Seasonality Move:
19.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-10 | 10Q | APYX/Apyx Medical Quarterly |
2020-05-11 | 10Q | APYX/Apyx Medical Quarterly |
2020-05-08 | 10Q | APYX/Apyx Medical Quarterly |
2020-03-31 | 10K | APYX/Apyx Medical Annual |
2019-11-15 | 10Q | APYX/Apyx Medical Quarterly |
2019-08-07 | 10Q | APYX/Apyx Medical Quarterly |
Receive APYX News And Ratings
See the #1 stock for the next 7 days that we like better than APYX
APYX Financial Statistics
Sales & Book Value
Annual Sales: | $52.35M |
---|---|
Cash Flow: | $-2.31M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.77 |
Price / Book: | 1.86 |
Profitability
EPS (TTM): | -0.54000 |
---|---|
Net Income (TTM): | $-18.71M |
Gross Margin: | $33.76M |
Return on Equity: | -54.64% |
Return on Assets: | -30.21% |
Apyx Medical Earnings Forecast
Key Apyx Medical Financial Ratios
- The Gross Profit Margin over the past 29 years for APYX is 64.49%.
- The Selling, General & Administrative Expenses for APYX have been equal to 93.35% of Gross Profit Margin.
- The Research & Development expenses have been 9.25% of Revenue.
- The Interest Expense is -13.24% of Operating Income.
- The Net Earning history of APYX is -35.75% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 12 years.
Apyx Medical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | APYX |
CUSIP: | 03837C |
Website: | apyxmedical.com |
Debt
Debt-to-Equity Ratio: | 1.24 |
---|---|
Current Ratio: | 5.52 |
Quick Ratio: | 4.53 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
APYX Technical Analysis vs Fundamental Analysis
Buy
56
Apyx Medical (APYX)
is a Buy
Is Apyx Medical a Buy or a Sell?
-
Apyx Medical stock is rated a Buy
The current Apyx Medical [APYX] share price is $1.43. The Score for APYX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.